| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TTE
|
75.53 | 168.0B | 12.72 | 1.57 | 5.35 | 9.7% | 7.3% | 63 | 61 | 97.93 | +22.2% | 75 | 0.52 |
|
EDP.LS
|
4.68 | 19.3B | 17.58 | 1.65 | 7.26 | 6.3% | 6.0% | 54 | 53 | 4.57 | -1.7% | 54 | 2.01 |
|
GTT
|
209.80 | 7.8B | 18.80 | 13.22 | 13.84 | 136.9% | 10.2% | 50 | 55 | 114.80 | -34.0% | 99 | 0.21 |
|
GALP.LS
|
21.40 | 14.5B | 28.45 | 3.50 | 6.87 | 21.2% | 7.6% | 42 | 53 | 12.44 | -31.4% | 69 | 1.05 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.